Language selection

Search

2008-01-08 - Female - 37 Years old

300159

Adverse reaction report number 300159
Latest AER version number 0
Market authorization holder AER number SPV1200705081
Initial received date 2008-01-08
Latest received date 2008-01-08
Age 37 Years
Gender Female
Weight N/A
Type of report Spontaneous
Reporter type Physician
Source of report MAH
Report outcome Recovered/resolved
Serious report? Yes

Reason for seriousness

Death
Disability
Cogenital anomaly
Life threateting
Hospitalization
Other medically important Yes

Product information

Product description Dosage form Health product role Route of administration Dose Frequency Therapy duration Indication(s)
ADDERALL XRCAPSULE, EXTENDED RELEASESuspectOral15 Milligram1 every 1 Day(s)8 Day(s)Attention deficit/hyperactivity disorder
WELLBUTRINTABLET (EXTENDED-RELEASE)ConcomitantUnknown

Adverse reaction term information

MedDRA version: v.21.1
Adverse reaction terms Reaction duration
Paranoia
Date modified: